Profile: Derma Sciences Inc (DSCI.OQ)

DSCI.OQ on NASDAQ Stock Exchange Capital Market

7.15USD
31 Jul 2015
Change (% chg)

$0.02 (+0.28%)
Prev Close
$7.13
Open
$7.17
Day's High
$7.25
Day's Low
$6.99
Volume
30,755
Avg. Vol
52,413
52-wk High
$10.11
52-wk Low
$6.39

Search Stocks

Derma Sciences, Inc. (Derma Sciences), incorporated on November 9, 1990, is a tissue regeneration company, which is engaged in the research and management of acute and chronic wounds, and burns. The Company operates through three segments: pharmaceutical wound care, advanced wound care and traditional wound care products. Pharmaceutical wound care products consist of DSC127, a product for the treatment of a variety of dermal applications. Advanced wound care products consist of differentiated dressings, bandages and ointments for wound healing and/or prevent infection. Traditional wound care products consist of commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closer strips, catheter fasteners and skin care products.

The Company markets its products through direct sales representatives in the United States, Canada and the United Kingdom, and through independent distributors within other select international markets. The Company's United States distribution facilities are located in St. Louis, Missouri and Houston, Texas. The Company utilizes third party distributors for distribution in Canada, Europe and the Far East. The Company has manufacturing facilities in Toronto, Canada and Nantong, China. It sells its products through distributors to health care providers, such as wound care centers, extended care facilities, acute care facilities, home health care agencies and physicians' offices.

Pharmaceutical Wound Care

The Company's pharmaceutical wound care segment is engaged in the development of DSC127 for diabetic foot ulcers and pre-clinical work on scar prevention. DSC127 for diabetic foot ulcers is in Phase III of clinical development.

Advanced Wound Care

The Company's advanced wound care product line consists of MEDIHONEY, TCC-EZ, AMNIOEXCEL and AMNIOMATRIX, XTRASORB and BIOGUARD. MEDIHONEY offers a line of dressings, consisting of Active Leptospermum Honey. MEDIHONEY dressings manage non-chronic and hard-to-heal wounds, including chronic ulcers, burns and post-operative wounds. TCC-EZ is an off-loading system for patients with diabetic foot ulcers. AMNIOEXCEL is an amniotic extracellular membrane product that is a sterile, room-temperature stable, re-absorbable tissue allograft derived from human amnion, providing a natural scaffold for tissue repair, reconstruction and replacement. AMNIOMATRIX is a cryopreserved liquid allograft derived from human placenta tissue used as a wound covering in the treatment of localized tissue defects. The addressable skin substitute market includes traumatic injuries, burns, surgical wounds, complex chronic and acute wounds, and other soft-tissue defects. XTRASORB provides a line of dressings that utilizes super-absorbent polymer technologies. XTRASORB dressings convert fluid within the dressings to a gel, thus locking the exudates into the dressings. BIOGUARD is a line of primary and secondary dressings containing an active antimicrobial compound. This compound, a cationic biocide, is intrinsically bound to the dressing through a process that results in the inability for the compound to separate from the dressing. These dressings prevent hospital or community acquired infections through wound sites, especially for burns. The Company's other advanced wound care products include ALGICELL AG, a antimicrobial dressing with ionic silver as its active ingredient; and a range of moist, occlusive dressings, such as hydrocolloids, foams, hydrogels, alginates, additional silver antimicrobial dressings, cleansers and DERMAGRAN products.

Traditional Wound Care

The Company's traditional wound care product line include a line of branded gauze sponges and bandages, non-adherent impregnated dressings, retention devices, paste bandages and other compression devices for the medical markets. It offers a line of branded and private-label adhesive bandages and related first aid products for the medical, industrial, private label and retail markets. The Company also offers private-label wound care products for the United States and international health care companies. It provides a line of wound closure strips, nasal tube fasteners and a variety of catheter fasteners for the medical markets. In addition, the Company offers a line of general purpose and specialized skin care products for the institutional medical market.

Company Address

Derma Sciences Inc

214 Carnegie Ctr Ste 300
PRINCETON   NJ   08540-6237
P: +1609.5144744

Company Web Links

Search Stocks